Abstract
The emphasis so far during the COVID-19 pandemic has been on the respiratory manifestations
with little attention being paid to cutaneous manifestations. The novel coronavirus
has a wide spectrum of cutaneous manifestations which are broadly divided into exanthematous
and vasculopathic type of lesions. The effects of this novel virus on the integumentary
system cannot be underestimated as it can mimic various types of viral skin lesions.
Thus, dermatologists should have knowledge about COVID-19 disease presentations and
which differential diagnosis to consider if they encounter skin lesions in a patient
who is known or suspected to have COVID-19. Patient evaluation and workup also needs
to be modified during the time of this pandemic. Immunosuppressive/immunomodulatory
drugs which are rampantly used in dermatological practice, must be used only after
weighing their risks and benefits during the COVID-19 era. Personal Protective Equipment
has to be worn when coming in contact with a suspected or a proven case of COVID-19.
However, its use itself is associated with dermatological side effects which should
be known to dermatologist practising during the COVID-19 era. Teledermatology can
go a long way in circumventing these issues and it should be made more accessible,
especially in remote areas. Another future recommendation could be setting up of a
national level organization or group for recording dermatological data related to
COVID-19.
Keywords
COVID-19 - cutaneous manifestations - SARS-CoV2 - teledermatology - viral mimicker
